(+)-dexrazoxane multiple interactions ISO RGD:1313987 6480464 [Dexrazoxane co-treated with Idarubicin] results in increased expression of XPC mRNA CTD PMID:28973540 (S)-colchicine decreases expression ISO RGD:1313986 6480464 Colchicine results in decreased expression of XPC mRNA CTD PMID:24211769 1,2-dimethylhydrazine multiple interactions ISO RGD:1313987 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of XPC mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:1313987 6480464 1, 2-Dimethylhydrazine results in increased expression of XPC mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1313987 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of XPC mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1313986 6480464 decitabine inhibits the reaction [Estradiol results in decreased expression of XPC mRNA] CTD PMID:22082530 17beta-estradiol decreases expression ISO RGD:1313986 6480464 Estradiol results in decreased expression of XPC mRNA CTD PMID:22082530 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1313986 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1313987 6480464 Tetrachlorodibenzodioxin results in increased expression of XPC mRNA CTD PMID:19428948 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of XPC mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313987 6480464 Tetrachlorodibenzodioxin affects the expression of XPC mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313987 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of XPC mRNA CTD PMID:17942748 2,4,6-tribromophenol decreases expression ISO RGD:1313986 6480464 2 more ... CTD PMID:31675489 2-acetamidofluorene decreases response to substance ISO RGD:1313987 6480464 XPC protein results in decreased susceptibility to 2-Acetylaminofluorene CTD PMID:23153559 2-hydroxypropanoic acid decreases expression ISO RGD:1313986 6480464 Lactic Acid results in decreased expression of XPC mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1313986 6480464 [3 more ... CTD PMID:19553035 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1313986 6480464 tetrabromobisphenol A results in decreased expression of XPC protein CTD PMID:31675489 4-hydroxynon-2-enal decreases expression ISO RGD:1313986 6480464 4-hydroxy-2-nonenal results in decreased expression of XPC mRNA CTD PMID:12419474 5-aza-2'-deoxycytidine decreases expression ISO RGD:1313986 6480464 Decitabine results in decreased expression of XPC mRNA CTD PMID:22082530 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1313986 6480464 Decitabine inhibits the reaction [Estradiol results in decreased expression of XPC mRNA] CTD PMID:22082530 acrolein multiple interactions ISO RGD:1313986 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPC mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPC mRNA CTD PMID:32699268 adenine decreases expression ISO RGD:1313986 6480464 Adenine results in decreased expression of XPC mRNA CTD PMID:24211769 aflatoxin B1 affects expression ISO RGD:1313986 6480464 Aflatoxin B1 affects the expression of XPC protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1313986 6480464 Aflatoxin B1 results in increased expression of XPC mRNA CTD PMID:21641981 more ... alpha-pinene multiple interactions ISO RGD:1313986 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPC mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPC mRNA CTD PMID:32699268 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of XPC mRNA CTD PMID:30779732 arsane affects expression ISO RGD:1313986 6480464 Arsenic affects the expression of XPC CTD PMID:21235219 arsane multiple interactions ISO RGD:1313986 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA, NFE2L1 protein alternative form inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA] CTD PMID:32188015 arsane affects response to substance ISO RGD:1313986 6480464 XPC gene SNP affects the susceptibility to Arsenic CTD PMID:25759212 arsenic atom affects expression ISO RGD:1313986 6480464 Arsenic affects the expression of XPC CTD PMID:21235219 arsenic atom multiple interactions ISO RGD:1313986 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA, NFE2L1 protein alternative form inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA] CTD PMID:32188015 arsenic atom affects response to substance ISO RGD:1313986 6480464 XPC gene SNP affects the susceptibility to Arsenic CTD PMID:25759212 arsenous acid affects response to substance ISO RGD:1313986 6480464 XPC protein affects the susceptibility to Arsenic Trioxide CTD PMID:20403967 , PMID:22280988 asbestos affects response to substance ISO RGD:1313986 6480464 XPC alternative form affects the susceptibility to Asbestos CTD PMID:28687356 ascaridole affects response to substance ISO RGD:1313986 6480464 XPC protein affects the susceptibility to ascaridole CTD PMID:22280988 benzene increases expression ISO RGD:1313987 6480464 Benzene results in increased expression of XPC mRNA CTD PMID:15342939 benzene increases expression ISO RGD:1313986 6480464 Benzene results in increased expression of XPC mRNA CTD PMID:19162166 benzene decreases expression ISO RGD:1313986 6480464 Benzene results in decreased expression of XPC mRNA CTD PMID:18724895 benzo[a]pyrene multiple interactions ISO RGD:1313987 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to XPC promoter], Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of XPC mRNA] CTD PMID:19654925 , PMID:30020114 benzo[a]pyrene increases expression ISO RGD:1313986 6480464 Benzo(a)pyrene results in increased expression of XPC mRNA, Benzo(a)pyrene results in increased expression of XPC protein CTD PMID:23894430 more ... benzo[a]pyrene decreases expression ISO RGD:1313986 6480464 Benzo(a)pyrene results in decreased expression of XPC mRNA, Benzo(a)pyrene results in decreased expression of XPC protein CTD PMID:19748547 , PMID:30020114 benzo[a]pyrene affects response to substance ISO RGD:1313986 6480464 XPC polyA tail polymorphism affects the susceptibility to Benzo(a)pyrene CTD PMID:15471894 benzo[a]pyrene multiple interactions ISO RGD:1313986 6480464 [3 more ... CTD PMID:19553035 , PMID:30020114 benzo[a]pyrene affects response to substance ISO RGD:1313987 6480464 XPC protein affects the susceptibility to Benzo(a)pyrene CTD PMID:16094661 benzo[a]pyrene increases expression ISO RGD:1313987 6480464 Benzo(a)pyrene results in increased expression of XPC mRNA CTD PMID:19428948 benzo[a]pyrene decreases expression ISO RGD:1313987 6480464 Benzo(a)pyrene results in decreased expression of XPC mRNA CTD PMID:20504355 , PMID:30020114 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1313986 6480464 7 more ... CTD PMID:18085531 , PMID:28593498 bis(2-ethylhexyl) phthalate affects response to substance ISO RGD:1313987 6480464 XPC protein affects the susceptibility to Diethylhexyl Phthalate CTD PMID:24084170 bisphenol A decreases methylation ISO RGD:1313986 6480464 bisphenol A results in decreased methylation of XPC promoter CTD PMID:30352284 bisphenol A decreases expression ISO RGD:1313986 6480464 bisphenol A results in decreased expression of XPC protein CTD PMID:31675489 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of XPC mRNA CTD PMID:34947998 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of XPC mRNA CTD PMID:25181051 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of XPC mRNA CTD PMID:24136188 buta-1,3-diene increases response to substance ISO RGD:1313987 6480464 XPC gene mutant form results in increased susceptibility to 1, 3-butadiene CTD PMID:16730686 cadmium dichloride decreases expression ISO RGD:1313986 6480464 Cadmium Chloride results in decreased expression of XPC mRNA CTD PMID:25596134 caffeine decreases phosphorylation ISO RGD:1313986 6480464 Caffeine results in decreased phosphorylation of XPC protein CTD PMID:35688186 carbazoles affects response to substance ISO RGD:1313986 6480464 XPC protein affects the susceptibility to Carbazoles CTD PMID:22280988 carbon nanotube decreases expression ISO RGD:1313987 6480464 Nanotubes more ... CTD PMID:25554681 carboplatin decreases response to substance ISO RGD:1313987 6480464 XPC results in decreased susceptibility to Carboplatin CTD PMID:19372135 CGP 52608 multiple interactions ISO RGD:1313986 6480464 CGP 52608 promotes the reaction [RORA protein binds to XPC gene] CTD PMID:28238834 chloroacetaldehyde decreases expression ISO RGD:1313986 6480464 chloroacetaldehyde results in decreased expression of XPC mRNA CTD PMID:25596134 chloroethene affects response to substance ISO RGD:1313986 6480464 XPC gene polymorphism affects the susceptibility to Vinyl Chloride CTD PMID:21216194 chlorpromazine decreases expression EXP 6480464 Chlorpromazine results in decreased expression of XPC mRNA CTD PMID:25596134 cidofovir anhydrous increases expression ISO RGD:1313986 6480464 Cidofovir results in increased expression of XPC mRNA CTD PMID:25596134 cisplatin multiple interactions ISO RGD:1313986 6480464 [sodium arsenite results in decreased expression of XPC protein] which results in increased susceptibility to Cisplatin more ... CTD PMID:21696631 more ... cisplatin increases expression ISO RGD:1313986 6480464 Cisplatin results in increased expression of XPC mRNA, Cisplatin results in increased expression of XPC protein CTD PMID:21532991 more ... cisplatin decreases expression ISO RGD:1313986 6480464 Cisplatin results in decreased expression of XPC mRNA CTD PMID:24211769 cisplatin affects response to substance ISO RGD:1313986 6480464 XPC protein affects the susceptibility to Cisplatin CTD PMID:22331493 cisplatin increases response to substance ISO RGD:1313986 6480464 XPC protein results in increased susceptibility to Cisplatin CTD PMID:21324906 cisplatin decreases response to substance ISO RGD:1313986 6480464 XPC protein results in decreased susceptibility to Cisplatin CTD PMID:21327329 copper atom multiple interactions ISO RGD:1313987 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of XPC mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1313987 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of XPC mRNA CTD PMID:15467011 coumarin decreases phosphorylation ISO RGD:1313986 6480464 coumarin results in decreased phosphorylation of XPC protein CTD PMID:35688186 cyclophosphamide affects expression EXP 6480464 Cyclophosphamide affects the expression of XPC mRNA CTD PMID:11056294 cyclophosphamide increases expression ISO RGD:1313986 6480464 Cyclophosphamide results in increased expression of XPC mRNA CTD PMID:29445054 cyclosporin A decreases response to substance ISO RGD:1313987 6480464 XPC protein results in decreased susceptibility to Cyclosporine CTD PMID:23153559 cyclosporin A decreases expression ISO RGD:1313986 6480464 Cyclosporine results in decreased expression of XPC mRNA CTD PMID:25596134 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of XPC mRNA CTD PMID:25596134 cylindrospermopsin increases expression ISO RGD:1313986 6480464 cylindrospermopsin results in increased expression of XPC mRNA CTD PMID:23726867 diarsenic trioxide affects response to substance ISO RGD:1313986 6480464 XPC protein affects the susceptibility to Arsenic Trioxide CTD PMID:20403967 , PMID:22280988 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of XPC mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:1313987 6480464 Dibutyl Phthalate results in decreased expression of XPC mRNA CTD PMID:31318015 diethylstilbestrol decreases response to substance ISO RGD:1313987 6480464 XPC protein results in decreased susceptibility to Diethylstilbestrol CTD PMID:23153559 dioxygen decreases expression ISO RGD:1313986 6480464 Oxygen deficiency results in decreased expression of XPC mRNA CTD PMID:25596134 doxorubicin affects expression ISO RGD:1313986 6480464 Doxorubicin affects the expression of XPC mRNA CTD PMID:29803840 ethyl methanesulfonate increases expression ISO RGD:1313986 6480464 Ethyl Methanesulfonate results in increased expression of XPC mRNA CTD PMID:23649840 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of XPC mRNA CTD PMID:25596134 folic acid multiple interactions ISO RGD:1313987 6480464 Folic Acid inhibits the reaction [1 more ... CTD PMID:22206623 , PMID:30020114 folic acid decreases expression ISO RGD:1313987 6480464 Folic Acid results in decreased expression of XPC mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1313986 6480464 Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of XPC mRNA] CTD PMID:30020114 formaldehyde increases expression ISO RGD:1313986 6480464 Formaldehyde results in increased expression of XPC mRNA CTD PMID:23649840 furan decreases expression EXP 6480464 furan results in decreased expression of XPC mRNA CTD PMID:22507866 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of XPC mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of XPC mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of XPC mRNA CTD PMID:24136188 gold atom decreases expression ISO RGD:1313986 6480464 Gold analog results in decreased expression of XPC mRNA CTD PMID:36057382 gold(0) decreases expression ISO RGD:1313986 6480464 Gold analog results in decreased expression of XPC mRNA CTD PMID:36057382 hydrogen peroxide increases expression ISO RGD:1313986 6480464 Hydrogen Peroxide results in increased expression of XPC mRNA CTD PMID:21751221 hydroxyurea increases expression ISO RGD:1313986 6480464 Hydroxyurea results in increased expression of XPC mRNA CTD PMID:18647660 idarubicin multiple interactions ISO RGD:1313987 6480464 [Dexrazoxane co-treated with Idarubicin] results in increased expression of XPC mRNA CTD PMID:28973540 ifosfamide increases expression ISO RGD:1313986 6480464 Ifosfamide results in increased expression of XPC mRNA CTD PMID:25596134 imiquimod increases expression ISO RGD:1313987 6480464 imiquimod results in increased expression of XPC mRNA CTD PMID:21878529 metformin decreases expression EXP 6480464 Metformin results in decreased expression of XPC mRNA CTD PMID:25596134 metformin increases expression EXP 6480464 Metformin results in increased expression of XPC mRNA CTD PMID:31324951 methyl methanesulfonate increases expression ISO RGD:1313986 6480464 Methyl Methanesulfonate results in increased expression of XPC mRNA CTD PMID:23649840 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO RGD:1313986 6480464 N more ... CTD PMID:33645215 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1313986 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in decreased expression of XPC protein] CTD PMID:28237621 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of XPC mRNA CTD PMID:24136188 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of XPC mRNA CTD PMID:24136188 nimustine increases expression ISO RGD:1313986 6480464 Nimustine results in increased expression of XPC mRNA CTD PMID:18089819 nimustine multiple interactions ISO RGD:1313986 6480464 TP53 affects the reaction [Nimustine results in increased expression of XPC mRNA] CTD PMID:18089819 Nonidet P-40 decreases expression ISO RGD:1313986 6480464 Nonidet P-40 results in decreased expression of XPC mRNA CTD PMID:26552463 ozone increases expression ISO RGD:1313986 6480464 Ozone results in increased expression of XPC mRNA CTD PMID:27206323 ozone multiple interactions ISO RGD:1313986 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPC mRNA more ... CTD PMID:32699268 paracetamol increases expression ISO RGD:1313986 6480464 Acetaminophen results in increased expression of XPC mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of XPC mRNA CTD PMID:33387578 paraquat affects response to substance ISO RGD:1313987 6480464 XPC protein affects the susceptibility to Paraquat CTD PMID:24084170 picoxystrobin decreases expression ISO RGD:1313986 6480464 picoxystrobin results in decreased expression of XPC mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:1313986 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of XPC mRNA CTD PMID:19710929 pirinixic acid affects response to substance ISO RGD:1313987 6480464 XPC protein affects the susceptibility to pirinixic acid CTD PMID:23153559 piroxicam multiple interactions ISO RGD:1313986 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of XPC mRNA] CTD PMID:21858171 piroxicam decreases expression ISO RGD:1313986 6480464 Piroxicam results in decreased expression of XPC mRNA CTD PMID:21858171 Ptaquiloside increases expression ISO RGD:1313986 6480464 ptaquiloside results in increased expression of XPC mRNA CTD PMID:22143989 quercetin increases expression EXP 6480464 Quercetin results in increased expression of XPC mRNA CTD PMID:17103110 quercetin affects response to substance ISO RGD:1313986 6480464 XPC protein affects the susceptibility to Quercetin CTD PMID:22280988 quercetin increases expression ISO RGD:1313986 6480464 Quercetin results in increased expression of XPC mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:1313986 6480464 Lactic Acid results in decreased expression of XPC mRNA CTD PMID:30851411 resveratrol decreases expression EXP 6480464 Resveratrol results in decreased expression of XPC mRNA CTD PMID:33775663 resveratrol multiple interactions ISO RGD:1313986 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of XPC mRNA CTD PMID:23557933 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of XPC mRNA CTD PMID:28374803 scopoletin affects response to substance ISO RGD:1313986 6480464 XPC protein affects the susceptibility to Scopoletin CTD PMID:22280988 sodium arsenite multiple interactions ISO RGD:1313986 6480464 [sodium arsenite results in decreased expression of XPC protein] which results in increased susceptibility to Cisplatin more ... CTD PMID:21696631 more ... sodium arsenite increases expression ISO RGD:1313987 6480464 sodium arsenite results in increased expression of XPC mRNA CTD PMID:25787150 sodium arsenite decreases expression ISO RGD:1313987 6480464 sodium arsenite results in decreased expression of XPC mRNA, sodium arsenite results in decreased expression of XPC protein CTD PMID:17558810 , PMID:28237621 sodium arsenite decreases expression ISO RGD:1313986 6480464 sodium arsenite results in decreased expression of XPC mRNA, sodium arsenite results in decreased expression of XPC protein CTD PMID:12377979 more ... sodium dichromate increases expression ISO RGD:1313987 6480464 sodium bichromate results in increased expression of XPC mRNA CTD PMID:31558096 sterigmatocystin increases expression ISO RGD:1313986 6480464 Sterigmatocystin results in increased expression of XPC mRNA CTD PMID:23296099 tetrachloromethane affects expression ISO RGD:1313987 6480464 Carbon Tetrachloride affects the expression of XPC mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of XPC mRNA CTD PMID:31150632 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of XPC mRNA CTD PMID:25596134 tungsten decreases expression ISO RGD:1313987 6480464 Tungsten results in decreased expression of XPC mRNA CTD PMID:30912803 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of XPC mRNA CTD PMID:24136188 valproic acid multiple interactions ISO RGD:1313986 6480464 Valproic Acid promotes the reaction [CREB1 protein binds to XPC promoter], Valproic Acid promotes the reaction [SP1 protein binds to XPC promoter] CTD PMID:21507255 valproic acid affects expression ISO RGD:1313986 6480464 Valproic Acid affects the expression of XPC mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1313986 6480464 Valproic Acid results in increased expression of XPC mRNA CTD PMID:21507255 Y-27632 increases expression ISO RGD:1313986 6480464 Y 27632 results in increased expression of XPC mRNA CTD PMID:20878077 zidovudine decreases response to substance ISO RGD:1313986 6480464 XPC protein results in decreased susceptibility to Zidovudine CTD PMID:21192964 zidovudine increases expression ISO RGD:1313986 6480464 Zidovudine results in increased expression of XPC mRNA, Zidovudine results in increased expression of XPC protein CTD PMID:21192964 , PMID:23675285
